Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)

NCT06667128 is registered in ClinicalTrials.gov with IRCCS Ospedale San Raffaele as lead sponsor.

NCT NCT06667128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06667128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Heart Failure (HF) Medical Therapy After Transcatheter Valve Intervention (TVI) in Patients With Heart Failure With Reduced Ejection Fraction (HFrEF)
Lead sponsor
IRCCS Ospedale San Raffaele
Phase
Not applicable
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
February 1, 2026
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic regurgitation disease, aortic stenosis, brain natriuretic peptide, heart failure, mitraclip, mitral regurgitation, tavi(transcatheter aortic valve implantation), tricuspid regurgitation, valvulopathy